Poor Outcomes in Patients With Transplant Glomerulopathy Independent of Banff Categorization or Therapeutic Interventions

Poor Outcomes in Patients With Transplant Glomerulopathy Independent of Banff Categorization or Therapeutic Interventions

BackgroundTransplant glomerulopathy (TG) may indicate different disease entities including chronic AMR (antibody-mediated rejection). However, AMR criteria have been frequently changed, and long-term outcomes of allografts with AMR and TG according to Banff 2017 have rarely been investigated.Methods...

Full description

Bibliographic Details
Main Authors: Kaiyin Wu, Danilo Schmidt, Covadonga López del Moral, Bilgin Osmanodja, Nils Lachmann, Fabian Halleck, Mira Choi, Friederike Bachmann, Simon Ronicke, Wiebke Duettmann, Marcel Naik, Eva Schrezenmeier, Birgit Rudolph, Klemens Budde
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Medicine
Subjects:
kidney transplantation
transplant glomerulopathy
chronic antibody-mediated rejection
antihumoral therapy
graft survival
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.889648/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2022.889648/full

Similar Items